Skip to main content

MARSHALL WACE, LLP

Position in MYGN — Myriad Genetics Inc

CIK 1318757 LONDON, X0

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,966,911
+$4,829,754 QoQ
Shares Held
1,103,758
+4849.1% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $530,118,500 across 25 Diagnostics & Research names. MYGN ranks #9 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,966,911 1,103,758
2025-12-31 $137,157 22,302
2025-09-30 $344,848 47,697
2025-06-30 $361,217 68,026
2024-09-30 $3,130,841 114,306
2024-03-31 $715,435 33,557
2022-12-31 $2,133,027 147,004
2022-03-31 $2,293,830 91,025
2020-09-30 $1,022,870 78,441
2020-06-30 $2,581,573 227,652